Roberta Torregrossa

2.4k total citations · 1 hit paper
39 papers, 1.5k citations indexed

About

Roberta Torregrossa is a scholar working on Biochemistry, Molecular Biology and Physiology. According to data from OpenAlex, Roberta Torregrossa has authored 39 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Biochemistry, 14 papers in Molecular Biology and 13 papers in Physiology. Recurrent topics in Roberta Torregrossa's work include Sulfur Compounds in Biology (26 papers), Eicosanoids and Hypertension Pharmacology (5 papers) and Nitric Oxide and Endothelin Effects (4 papers). Roberta Torregrossa is often cited by papers focused on Sulfur Compounds in Biology (26 papers), Eicosanoids and Hypertension Pharmacology (5 papers) and Nitric Oxide and Endothelin Effects (4 papers). Roberta Torregrossa collaborates with scholars based in United Kingdom, United States and Poland. Roberta Torregrossa's co-authors include Matthew Whiteman, Mark E. Wood, Miloš R. Filipović, Gary F. Baxter, Qutuba G. Karwi, Bob L. Smiley, G P Thill, Knut Madden, G. R. Davis and Domokos Gerő and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Biotechnology and PLANT PHYSIOLOGY.

In The Last Decade

Roberta Torregrossa

38 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hydrogen sulfide is neuroprotective in Alzheimer’s disease by sulfhydrating GSK3β and inhibiting Tau hyperphosphorylation

2021 195 citations Biljana Bursać, Juan I. Sbodio et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roberta Torregrossa United Kingdom	19	824	699	291	176	126	39	1.5k
Takaaki Akaike Japan	10	409 0.5×	372 0.5×	425 1.5×	82 0.5×	90 0.7×	12	1.1k
Katarzyna A. Broniowska United States	25	328 0.4×	816 1.2×	699 2.4×	75 0.4×	188 1.5×	43	1.9k
Long N. Nguyen Singapore	20	349 0.4×	1.2k 1.7×	463 1.6×	44 0.3×	112 0.9×	38	2.4k
Céline Ransy France	9	364 0.4×	318 0.5×	125 0.4×	89 0.5×	75 0.6×	14	839
Eva-Maria Hanschmann Germany	20	218 0.3×	1.2k 1.8×	201 0.7×	37 0.2×	178 1.4×	39	1.9k
R. William Caldwell United States	16	215 0.3×	451 0.6×	462 1.6×	33 0.2×	233 1.8×	24	1.5k
Daniel J.M. Fernández‐Ayala Spain	22	241 0.3×	1.3k 1.8×	272 0.9×	41 0.2×	151 1.2×	32	1.8k
Ramasamy Tamizhselvi India	18	277 0.3×	262 0.4×	167 0.6×	81 0.5×	150 1.2×	50	949
Pei-Hsuan Wu United States	15	140 0.2×	1.3k 1.9×	607 2.1×	46 0.3×	82 0.7×	19	2.0k
Klaus-D. Kröncke Germany	15	146 0.2×	447 0.6×	440 1.5×	38 0.2×	171 1.4×	18	1.4k

Countries citing papers authored by Roberta Torregrossa

Since Specialization

Citations

This map shows the geographic impact of Roberta Torregrossa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta Torregrossa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta Torregrossa more than expected).

Fields of papers citing papers by Roberta Torregrossa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta Torregrossa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta Torregrossa. The network helps show where Roberta Torregrossa may publish in the future.

Co-authorship network of co-authors of Roberta Torregrossa

This figure shows the co-authorship network connecting the top 25 collaborators of Roberta Torregrossa. A scholar is included among the top collaborators of Roberta Torregrossa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberta Torregrossa. Roberta Torregrossa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Torregrossa, Roberta, et al.. (2025). The mitochondria-targeted hydrogen sulfide donor AP39 reduces cortical stroke volume and improves motor function in a photothrombotic stroke model in mice in a sex-dependent manner. Neuropharmacology. 279. 110602–110602. 1 indexed citations

Dugbartey, George J., L.L. Penney, Smriti Juriasingani, et al.. (2025). AP39, a novel mitochondria-targeted hydrogen sulfide donor, promotes cutaneous wound healing in an in vivo murine model of acute frostbite injury. Biomedicine & Pharmacotherapy. 183. 117869–117869. 1 indexed citations

Stachowicz, Aneta, Anna Wiśniewska, Beata Kuśnierz‐Cabala, et al.. (2024). Mitochondria-targeted hydrogen sulfide donor reduces fatty liver and obesity in mice fed a high fat diet by inhibiting de novo lipogenesis and inflammation via mTOR/SREBP-1 and NF-κB signaling pathways. Pharmacological Research. 209. 107428–107428. 8 indexed citations

Stachowicz, Aneta, Anna Wiśniewska, Bartosz Pomierny, et al.. (2024). Mitochondria-targeted hydrogen sulfide donor reduces atherogenesis by changing macrophage phenotypes and increasing UCP1 expression in vascular smooth muscle cells. Biomedicine & Pharmacotherapy. 180. 117527–117527. 2 indexed citations

Potor, László, Péter Nagy, Tamás Ditrói, et al.. (2023). Hydrogen sulfide as an anti-calcification stratagem in human aortic valve: Altered biogenesis and mitochondrial metabolism of H2S lead to H2S deficiency in calcific aortic valve disease. Redox Biology. 60. 102629–102629. 19 indexed citations

Magierowska, Katarzyna, Dagmara Wójcik, Aleksandra Danielak, et al.. (2023). The mitochondria-targeted sulfide delivery molecule attenuates drugs-induced gastropathy. Involvement of heme oxygenase pathway.. Redox Biology. 66. 102847–102847. 10 indexed citations

Scuffi, Denise, Alex Costa, Elina Welchen, et al.. (2022). Mitochondrial H2S donor AP39 induces stomatal closure by modulating guard cell mitochondrial activity. PLANT PHYSIOLOGY. 191(3). 2001–2011. 16 indexed citations

Lewis, Jonathan, Roberta Torregrossa, Mathew Piasecki, et al.. (2022). Sulfur amino acid supplementation displays therapeutic potential in a C. elegans model of Duchenne muscular dystrophy. Communications Biology. 5(1). 1255–1255. 14 indexed citations

Magierowska, Katarzyna, Dagmara Wójcik, Zbigniew Śliwowski, et al.. (2022). Mitochondria-targeted hydrogen sulfide donors versus acute oxidative gastric mucosal injury. Journal of Controlled Release. 348. 321–334. 26 indexed citations

10.

Hewitt, Jennifer, Roberta Torregrossa, Ashleigh M. Philp, et al.. (2021). Mitochondrial hydrogen sulfide supplementation improves health in the C. elegans Duchenne muscular dystrophy model. Proceedings of the National Academy of Sciences. 118(9). 33 indexed citations

11.

Bursać, Biljana, Juan I. Sbodio, Thibaut Vignane, et al.. (2021). Hydrogen sulfide is neuroprotective in Alzheimer’s disease by sulfhydrating GSK3β and inhibiting Tau hyperphosphorylation. Proceedings of the National Academy of Sciences. 118(4). 195 indexed citations breakdown →

12.

Chaiprasongsuk, Anyamanee, et al.. (2021). Mitochondria-Targeted Hydrogen Sulfide Delivery Molecules Protect Against UVA-Induced Photoaging in Human Dermal Fibroblasts, and in Mouse Skin In Vivo. Antioxidants and Redox Signaling. 36(16-18). 1268–1288. 25 indexed citations

13.

Allen, Claire, Andrew V. Benest, Mark E. Wood, et al.. (2021). Hydrogen Sulfide Is a Novel Protector of the Retinal Glycocalyx and Endothelial Permeability Barrier. Frontiers in Cell and Developmental Biology. 9. 724905–724905. 10 indexed citations

14.

Torregrossa, Roberta, et al.. (2021). GYY4137 and Sodium Hydrogen Sulfide Relaxations Are Inhibited by L-Cysteine and KV7 Channel Blockers in Rat Small Mesenteric Arteries. Frontiers in Pharmacology. 12. 613989–613989. 15 indexed citations

15.

Potor, László, Tamás Szerafin, Melinda Oros, et al.. (2019). Hydrogen sulfide inhibits calcification of heart valves; implications for calcific aortic valve disease. British Journal of Pharmacology. 177(4). 793–809. 21 indexed citations

16.

Vitvitsky, Victor, Jan Lj. Miljković, Bikash Adhikari, et al.. (2018). CytochromecReduction by H₂S Potentiates Sulfide Signaling. ACS Chemical Biology. 13(8). 2300–2307. 79 indexed citations

17.

Rodrigues, A. David, Simone A. Teixeira, António G. Soares, et al.. (2016). Hydrogen sulfide donors alleviate itch secondary to the activation of type-2 protease activated receptors (PAR-2) in mice. Pharmacological Research. 113(Pt A). 686–694. 16 indexed citations

18.

Gerő, Domokos, Roberta Torregrossa, Alexis Perry, et al.. (2016). The novel mitochondria-targeted hydrogen sulfide (H 2 S) donors AP123 and AP39 protect against hyperglycemic injury in microvascular endothelial cells in vitro. Pharmacological Research. 113(Pt A). 186–198. 142 indexed citations

19.

Karwi, Qutuba G., Matthew Whiteman, Mark E. Wood, Roberta Torregrossa, & Gary F. Baxter. (2016). Pharmacological postconditioning against myocardial infarction with a slow-releasing hydrogen sulfide donor, GYY4137. Pharmacological Research. 111. 442–451. 58 indexed citations

20.

Lobb, Ian, J. Jiang, Aaron Haig, et al.. (2016). Hydrogen Sulfide Protects Renal Grafts Against Prolonged Cold Ischemia–Reperfusion Injury via Specific Mitochondrial Actions. American Journal of Transplantation. 17(2). 341–352. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact